Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
59.49
-2.33 (-3.77%)
At close: Jul 20, 2026, 4:00 PM EDT
59.31
-0.18 (-0.30%)
After-hours: Jul 20, 2026, 7:58 PM EDT
Moderna Revenue
Moderna had revenue of $389.00M in the quarter ending March 31, 2026, with 260.19% growth. This brings the company's revenue in the last twelve months to $2.23B, down -29.97% year-over-year. In the year 2025, Moderna had annual revenue of $1.94B, down -39.93%.
Revenue (ttm)
$2.23B
Revenue Growth
-29.97%
P/S Ratio
10.61
Revenue / Employee
$473,404
Employees
4,700
Market Cap
23.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.94B | -1.29B | -39.93% |
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines AG | 5.74B |
| Incyte | 5.36B |
| Jazz Pharmaceuticals | 4.44B |
| Alnylam Pharmaceuticals | 4.29B |
| Genmab | 3.90B |
| BioNTech SE | 3.23B |
| Royalty Pharma | 2.44B |
| Ascendis Pharma | 998.25M |
MRNA News
- 4 days ago - Moderna announces first participant dosed in Phase 1 trial of mRNA-4200 - TheFly
- 4 days ago - Arbutus Biopharma receives $178M settlement agreement from Moderna - TheFly
- 4 days ago - Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors - Accesswire
- 10 days ago - Here’s Why Moderna Stock (MRNA) Is Crashing Today — July 10, 2026 - TipRanks
- 10 days ago - Moderna falls -10.7% - TheFly
- 10 days ago - Moderna falls -8.2% - TheFly
- 11 days ago - Moderna wins EU contract for RSV vaccine supply - Reuters
- 11 days ago - Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026 - Accesswire